The compounds of formula (I), wherein n is an integer from 0 to 4; R1 is a radical selected from the group consisting of H, CH.sub.3, CH.sub.2-CH.sub.3, C(CH.sub.3).sub.3, COOH, CONH.sub.2 and C.ident.CH; R2, R3, R4 and R5 are radicals independently selected from the group consisting of H, F, Cl, Br, (C.sub.1-C.sub.3)-alkoxyl and (C.sub.1-C.sub.4)-alkyl; and R6 is a radical selected from the group consisting of H, F, Cl, Br, (C.sub.1-C.sub.3)-alkoxyl, (C.sub.1-C.sub.4)-alkyl, R7, CH.dbd.CH--R7 and O--CH.sub.2--R7; wherein R7 is phenyl or phenyl mono- or independently di-substituted with F, Cl, Br, (C.sub.1-C.sub.3)-alkoxyl or (C.sub.1-C.sub.4)-alkyl, exhibit a similar chemotactic index to that of amygdalin (natural product whose chemotaxis profile is similar to that of peptide T) and, consequently, are useful for treating inflammatory and/or allergic dermatophathies, such as psoriasis, and are especially much less toxic than amygdalin. ##STR00001##

amygdalin/athlasadh

Use of amygdalin analogues for the treatment of psoriasis

An bunachar luibheanna míochaine is iomláine le tacaíocht ón eolaíocht